Čájehuvvo
1
- 3
/
3
Sirdás sisdollui
Čálihuva
Giella
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Māori
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Oza
Aiddostahtton
Dahkki
Benjamin Wuest
Ohcanbohtosat - Benjamin Wuest
Čájehuvvo
1
- 3
/
3
Aiddostahte ozu
Ordne
Relevánsa
Jahki (vuohččan ođđaseamos)
Jahki (vuohččan boarráseamos)
Luohkká
Dahkki
Bajilčálus
1
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
Dahkki
Celine Kaegi
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
Almmustuhtton 2022
Viečča ollesdeavstta
Viečča ollesdeavstta
Revisão
Lasit oiddohiidda
Furkejuvvon:
2
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
Dahkki
Celine Kaegi
,
Urs C. Steiner
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
Almmustuhtton 2020
Viečča ollesdeavstta
Viečča ollesdeavstta
Artigo
Lasit oiddohiidda
Furkejuvvon:
3
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
Dahkki
Celine Kaegi
,
Benjamin Wuest
,
Jens Schreiner
,
Urs C. Steiner
,
Alessandra Vultaggio
,
Andrea Matucci
,
Catherine Crowley
,
Onur Boyman
Almmustuhtton 2019
Viečča ollesdeavstta
Viečča ollesdeavstta
Revisão
Lasit oiddohiidda
Furkejuvvon:
Ohcanreaiddut:
RSS-biepmus
Sádde ozu šleađgaboasttain
Laktáseaddji fáttát
Antibody
Immunology
Medicine
Etanercept
Internal medicine
Rheumatoid arthritis
Rituximab
Adverse effect
B cell
B-cell activating factor
Belimumab
CD20
Clinical trial
Dermatology
Immune system
Obinutuzumab
Ocrelizumab
Ofatumumab
Oncology
Please ensure Javascript is enabled for purposes of
website accessibility